Evaluation of Efficacy and Hypothalamus-pituitary-adrenal Axis Suppression Due to Corticosteroids Intrabursal Injection

• Status: Completed
• Trial end date: 2013-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare the efficacy and effects on the hypothalamus-pituitary-adrenal axis of a single intrabursal injection of two different types of corticosteroids (methylprednisolone and triamcinolone) in patients with calcific shoulder tendinopathy.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Istituto Ortopedico Rizzoli
• Collaborator: Azienda Ospedaliera San Giovanni Battista
• Treatments: Epinephrine; Epinephryl borate; Methylprednisolone; Methylprednisolone Acetate; Methylprednisolone Hemisuccinate; Prednisolone; Prednisolone acetate; Prednisolone hemisuccinate; Prednisolone phosphate; Racepinephrine; Triamcinolone; Triamcinolone Acetonide; Triamcinolone diacetate; Triamcinolone hexacetonide

Criteria

Inclusion Criteria:

• painful rotator cuff calcific tendonitis demonstrated by ultrasounds

Exclusion Criteria:

• pregnancy

• use of corticosteroids in the previous 2 months

• systemic chronic inflammatory or allergic diseases

• allergy to methylprednisolone or triamcinolone

• diabetes

• glaucoma

• coagulopathies or current treatment with antiaggregants or anticoagulants

• septic arthritis or infections

• calcific enthesopathy